Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.67M 8,208 sh | May 11, 2026 |
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.71M 8,477 sh | May 11, 2026 traded May 7, 2026 |
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $9.03M 45.5K sh | May 11, 2026 traded May 7, 2026 |
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.22M 11.4K sh | May 11, 2026 traded May 7, 2026 |
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.71M 8,603 sh | May 11, 2026 traded May 7, 2026 |
| 17 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.11M 5,678 sh | May 11, 2026 traded May 7, 2026 |
| 16 | Foff Erin PennockChief Medical Officer |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $123K 4,321 sh | May 11, 2026 traded May 7, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 6,979 sh | May 11, 2026 traded May 11, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $177K 5,808 sh | May 11, 2026 traded May 11, 2026 |
| 16 | Sentonas MichaelPRESIDENT | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 20 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $333K 1,640 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $362K 1,804 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $444K 2,288 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $605K 3,104 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $333K 1,640 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $729K 3,415 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $268K 1,311 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $640K 3,146 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $605K 3,104 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $598K 2,915 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $551K 2,702 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $900K 4,568 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $912K 4,725 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $343K 1,696 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $362K 1,804 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $436K 2,182 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $444K 2,287 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $343K 1,696 sh | May 11, 2026 traded May 7, 2026 |
| 14 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $436K 2,182 sh | May 11, 2026 traded May 7, 2026 |
| 13 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,405 117 sh | May 11, 2026 traded May 7, 2026 |
| 13 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $7,841 284 sh | May 11, 2026 traded May 11, 2026 |
| 13 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 846 sh | May 11, 2026 traded May 11, 2026 |
| 13 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $32K 30.0K sh | May 11, 2026 traded May 1, 2026 |
| 12 | Atwood Catherine RSVP and General Counsel |  RMRegional Management Corp.Open-market sale · 10b5-1 plan | SELL | $105K 3,000 sh | May 11, 2026 traded May 11, 2026 |
| 11 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $110K 541 sh | May 11, 2026 traded May 7, 2026 |
| 11 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $180K 914 sh | May 11, 2026 traded May 7, 2026 |
| 11 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $240K 1,163 sh | May 11, 2026 traded May 7, 2026 |
| 11 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $198K 960 sh | May 11, 2026 traded May 7, 2026 |
| 11 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $183K 946 sh | May 11, 2026 traded May 7, 2026 |
| 11 | Gajendra SanjayDirector, President and COO | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $110K 541 sh | May 11, 2026 traded May 7, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K